|
|
Pharmacoepidemiology & Pharmacogenomics Resources:
Mention of companies, products or services on this Web site is for reference purposes only
and does not constitute endorsement by NCI or the US Government.
Please read our disclaimer. |
|
|
Evaluation of Genomic Applications in Practice and Prevention (EGAPP)
Description
Evaluation of Genomic Applications in Practice and Prevention (EGAPP) is a pilot
project initiated by the CDC National Office of Public Health Genomics in the fall of
2004. The project's goal is to establish and evaluate a systematic, evidence-based process
for assessing genetic tests and other applications of genomic technology in transition
from research to clinical and public health practice. EGAPP aims to integrate:
- existing recommendations on implementation of genetic tests from professional
organizations and advisory committees; and
- knowledge and experience gained from existing processes for evaluation and appraisal,
previous CDC initiatives, and the international health technology assessment experience.
|
|
